Founded in 2021 and based in Oxford, United Kingdom, Human Centric Drug Discovery is a biotechnology company that specializes in identifying and validating drugs for neurological diseases. The company combines data from induced pluripotent stem cells, large-scale genetic studies, and population health data to discover novel drug targets for licensing and in-house development. With a focus on significantly de-risked drug discovery, Human Centric Drug Discovery aims to contribute to the advancement of treatments for neurological diseases.